For the quarter ended June 30, 2025
- Net sales of $1.0755 billion, increased 10.8% sequentially and declined 13.4% from the year ago quarter. The midpoint of our updated guidance provided on May 29, 2025 was net sales of $1.0575 billion.
- On a GAAP basis: gross profit of 53.6%; operating income of $32.1 million and 3.0% of net sales; net loss attributable to common stockholders of $46.4 million; and loss of $0.09 per diluted share. Our updated guidance provided on May 29, 2025 was for GAAP EPS loss per diluted share of $0.11 to $0.07.
- On a Non-GAAP basis: gross profit of 54.3%; operating income of $222.3 million and 20.7% of net sales; net income of $154.7 million; and EPS of $0.27 per diluted share. Our updated guidance provided on May 29, 2025 was for Non-GAAP EPS per diluted share of $0.22 to $0.26.
- Returned approximately $245.5 million to common stockholders in the June quarter through dividends.
- Quarterly dividend on common stock declared for the September quarter of 45.5 cents per share.
CHANDLER, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) — (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of smart, connected, and secure embedded control solutions, today reported results for the three months ended June 30, 2025.
Steve Sanghi, Microchip’s CEO and President commented that “Fiscal 2026 is off to a strong start as revenue grew 10.8% sequentially to approximately $1.0755 billion, well ahead of our revised guidance. As we execute our strategic imperatives under our nine-point recovery plan, we are seeing improvements across key financial metrics and emerging from the prolonged industry downturn with enhanced operational capabilities and a strengthened financial position. The momentum from the March quarter has accelerated into fiscal 2026, validating our strategic plan and positioning us well to capitalize on the recovery.”
Mr. Sanghi added, “As a key objective of our recovery plan, we delivered a substantial inventory reduction in the June quarter, reducing overall inventory dollars by $124.4 million, with distribution inventory days reduced by 4 days to 29 days and inventory days on our balance sheet declining to 214 days, improving our working capital efficiency. This continued progress on our inventory optimization demonstrates the effectiveness of our manufacturing improvements and positions us with increased operational flexibility as demand conditions continue to strengthen.”
Eric Bjornholt, Microchip’s Chief Financial Officer, said, “Our first quarter results highlight the leverage in our business model, with incremental non-GAAP gross margins of 76% and incremental non-GAAP operating margins of 82% showcasing our ability to translate revenue growth directly to profitability. We achieved solid sequential margin expansion driven by operational improvements, including declining inventory write-offs and reduced underutilization charges. As we execute our strategic plan and benefit from improving demand conditions, we expect this operational leverage to support sustained margin expansion and enhanced cash flow generation as we drive towards our long-term business model goals.”
Rich Simoncic, Microchip’s Chief Operating Officer, said, “Our Total System Solutions strategy continues to secure design wins with tier-one cloud providers for AI infrastructure and defense applications amid accelerating global defense spending. These design wins position us at the center of two secular growth trends where our integrated solutions, combining processing power, security, and energy efficiency, are essential.”
Mr. Sanghi concluded, “Inventory destocking has continued to occur at our customers, channel partners and their downstream customers. The trifecta effect we have discussed, including recovery in distributor sell-through, narrowing of distributor sell-in and sell-out gaps, and normalization of direct customer inventory, is driving our revenue growth. Our September quarter backlog is running ahead of June quarter levels, and July bookings were the highest since July 2022. Customer engagement levels continue strengthening across our diversified end markets. Taking all these factors into account, we expect September quarter net sales of $1.130 billion plus or minus $20.0 million, representing approximately 5.1% sequential growth at the midpoint. While we are maintaining a disciplined approach given the evolving macro environment, we believe we are well-positioned to deliver sustained growth and enhanced shareholder value as we execute our strategic roadmap throughout fiscal 2026.”
The following table summarizes Microchip’s reported result for the three months ended June 30, 2025.
Three Months Ended June 30, 2025(1) | ||||||||||
Net sales | $ | 1,075.5 | ||||||||
GAAP | % | Non-GAAP(2) | % | |||||||
Gross profit | $ | 576.7 | 53.6 | % | $ | 584.4 | 54.3 | % | ||
Operating income | $ | 32.1 | 3.0 | % | $ | 222.3 | 20.7 | % | ||
Other expense | $ | (47.9 | ) | $ | (47.9 | ) | ||||
Income tax provision | $ | 2.8 | $ | 19.7 | ||||||
Net (loss) income | $ | (18.6 | ) | $ | 154.7 | |||||
Dividends on Series A Preferred Stock | $ | (27.8 | ) | — | ||||||
Net (loss) income attributable to common stockholders | $ | (46.4 | ) | (4.3 | )% | $ | 154.7 | 14.4 | % | |
Diluted net (loss) income per common share | $ | (0.09 | ) | $ | 0.27 |
(1) In millions, except per share amounts and percentages of net sales.
(2) See the “Use of Non-GAAP Financial Measures” section of this release.
Net sales for the first quarter of fiscal 2026 were $1.0755 billion, down 13.4% from net sales of $1.241 billion in the prior year’s first fiscal quarter.
GAAP net loss attributable to common stockholders for the first quarter of fiscal 2026 was $46.4 million, or $0.09 per diluted share, down from GAAP net income attributable to common stockholders of $129.3 million, or $0.24 per diluted share, in the prior year’s first fiscal quarter. For the first quarters of fiscal 2026 and fiscal 2025, GAAP results were adversely impacted by amortization of acquired intangible assets associated with our previous acquisitions.
Non-GAAP net income for the first quarter of fiscal 2026 was $154.7 million, or $0.27 per diluted share, down from non-GAAP net income of $289.9 million, or $0.53 per diluted share, in the prior year’s first fiscal quarter. For the first quarters of fiscal 2026 and fiscal 2025, our non-GAAP results exclude the effect of share-based compensation, restructuring charges, expenses related to our acquisition activities (including intangible asset amortization, severance, and other restructuring costs, and legal and other general and administrative expenses associated with acquisitions including legal fees and expenses for litigation and investigations related to our Microsemi acquisition), professional services associated with certain legal matters, and dividends on our Series A Mandatory Convertible Preferred Stock. For the first quarters of fiscal 2026 and fiscal 2025, our non-GAAP income tax expense is presented based on projected cash taxes for the applicable fiscal year, excluding transition tax payments under the Tax Cuts and Jobs Act. A reconciliation of our non-GAAP and GAAP results is included in this press release.
Microchip announced today that its Board of Directors declared a quarterly cash dividend on its common stock of 45.5 cents per share, which is payable on September 5, 2025 to stockholders of record on August 22, 2025. The Microchip Board also declared a quarterly cash dividend on Microchip’s 7.50% Series A Mandatory Convertible Preferred Stock of $18.750 per share (which represents $0.9375 per depositary share) which is payable on September 15, 2025 to stockholders of record on September 1, 2025.
Second Quarter Fiscal Year 2026 Outlook:
The following statements are based on current expectations. These statements are forward-looking, and actual results may differ materially.
Microchip Consolidated Guidance | |||
Net Sales | $1.110 to $1.150 billion | ||
GAAP(5) | Non-GAAP Adjustments(1) | Non-GAAP(1) | |
Gross Profit | 54.3% to 56.2% | $7.7 to $8.7 million | 55.0% to 57.0% |
Operating Expenses(2) | 47.4% to 48.0% | $168.8 to $172.8 million | 32.4% to 32.8% |
Operating Income | 6.3% to 8.8% | $176.5 to $181.5 million | 22.2% to 24.6% |
Other Expense, net | $54.7 to $55.3 million | $(0.2) to $0.2 million | $54.5 to $55.5 million |
Income Tax Provision | $10.2 to $23.4 million(3) | $(1.7) to $7.9 million | $18.1 to $21.7 million(4) |
Net income | $4.4 to $23.4 million | $168.4 to $183.3 million | $172.8 to $206.7 million |
Dividends on Series A Preferred Stock | $(27.8) million | $27.8 million | — |
Net (loss) income attributable to common stockholders | $(23.5) to $(4.5) million | $196.3 to $211.2 million | $172.8 to $206.7 million |
Diluted Common Shares Outstanding | Approximately 539.8 million shares | 28.5 to 29.5 million shares | Approximately 568.3 to 569.3 million shares |
Diluted net (loss) per common share | $(0.04) to $(0.01) | $0.34 to $0.37 | $0.30 to $0.36 |
(1) See the “Use of Non-GAAP Financial Measures” section of this release for information regarding our non-GAAP guidance.
(2) We are not able to estimate the amount of certain Special Charges and Other, net that may be incurred during the quarter ending September 30, 2025. Therefore, our estimate of GAAP operating expenses excludes certain amounts that may be recognized as Special Charges and Other, net in the quarter ending September 30, 2025.
(3) The forecast for GAAP tax expense excludes any unexpected tax events that may occur during the quarter, as these amounts cannot be forecasted.
(4) Represents the expected cash tax rate for fiscal 2026, excluding any transition tax payments associated with the Tax Cuts and Jobs Act.
(5) Our GAAP guidance excludes the impact of any potential charges related to our ongoing evaluation of restructuring activities.
Capital expenditures for the quarter ending September 30, 2025 are expected to be between $35 million and $40 million. Capital expenditures for all of fiscal 2026 are expected to be at or below $100 million. Consistent with the slow macroeconomic environment in fiscal 2025, we have paused most of our factory expansion actions and reduced our planned capital investments through fiscal 2026. However, we are adding capital equipment to selectively expand our production capacity and add research and development equipment.
Under the GAAP revenue recognition standard, we are required to recognize revenue when control of the product changes from us to a customer or distributor. We focus our sales and marketing efforts on creating demand for our products in the end markets we serve and not on moving inventory into our distribution network. We also manage our manufacturing and supply chain operations, including our distributor relationships, towards the goal of having our products available at the time and location the end customer desires.
Use of Non-GAAP Financial Measures: Our non-GAAP adjustments, where applicable, include the effect of share-based compensation, restructuring charges, expenses related to our acquisition activities (including intangible asset amortization, severance, and other restructuring costs, and legal and other general and administrative expenses associated with acquisitions including legal fees and expenses for litigation and investigations related to our Microsemi acquisition), professional services associated with certain legal matters, and dividends on our Series A Mandatory Convertible Preferred Stock. For the first quarters of fiscal 2026 and fiscal 2025, our non-GAAP income tax expense is presented based on projected cash taxes for the fiscal year, excluding transition tax payments under the Tax Cuts and Jobs Act.
We are required to estimate the cost of certain forms of share-based compensation, including restricted stock units and our employee stock purchase plan, and to record a commensurate expense in our income statement. Share-based compensation expense is a non-cash expense that varies in amount from period to period and is affected by the price of our stock at the date of grant. The price of our stock is affected by market forces that are difficult to predict and are not within the control of management. Our other non-GAAP adjustments are either non-cash expenses, unusual or infrequent items, or other expenses related to transactions. Management excludes all of these items from its internal operating forecasts and models.
We are using non-GAAP operating expenses in dollars, including non-GAAP research and development expenses and non-GAAP selling, general and administrative expenses, non-GAAP other expense, net, and non-GAAP income tax rate, which exclude the items noted above, as applicable, to permit additional analysis of our performance.
Management believes these non-GAAP measures are useful to investors because they enhance the understanding of our historical financial performance and comparability between periods. Many of our investors have requested that we disclose this non-GAAP information because they believe it is useful in understanding our performance as it excludes non-cash and other charges that many investors feel may obscure our underlying operating results. Management uses non-GAAP measures to manage and assess the profitability of our business and for compensation purposes. We also use our non-GAAP results when developing and monitoring our budgets and spending. Our determination of these non-GAAP measures might not be the same as similarly titled measures used by other companies, and it should not be construed as a substitute for amounts determined in accordance with GAAP. There are limitations associated with using these non-GAAP measures, including that they exclude financial information that some may consider important in evaluating our performance. Management compensates for this by presenting information on both a GAAP and non-GAAP basis for investors and providing reconciliations of the GAAP and non-GAAP results.
Generally, gross profit fluctuates over time, driven primarily by the mix of products sold and licensing revenue; variances in manufacturing yields; fixed cost absorption; wafer fab loading levels; costs of wafers from foundries; inventory reserves; pricing pressures in our non-proprietary product lines; and competitive and economic conditions. Operating expenses fluctuate over time, primarily due to net sales and profit levels.
Diluted Common Shares Outstanding can vary for, among other things, the trading price of our common stock, the vesting of restricted stock units, the potential for incremental dilutive shares from our convertible debentures and our mandatory convertible preferred stock (additional information regarding our share count is available in the investor relations section of our website under the heading “Supplemental Information”), and repurchases or issuances of shares of our common stock. The diluted common shares outstanding presented in the guidance table above assumes an average Microchip stock price in the September 2025 quarter between $65 and $75 per share (however, we make no prediction as to what our actual share price will be for such period or any other period).
MICROCHIP TECHNOLOGY INCORPORATED AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share amounts; unaudited) |
|||||||
Three Months Ended June 30, | |||||||
2025 | 2024 | ||||||
Net sales | $ | 1,075.5 | $ | 1,241.3 | |||
Cost of sales | 498.8 | 504.4 | |||||
Gross profit | 576.7 | 736.9 | |||||
Research and development | 255.5 | 241.7 | |||||
Selling, general and administrative | 159.3 | 150.5 | |||||
Amortization of acquired intangible assets | 107.6 | 123.0 | |||||
Special charges and other, net | 22.2 | 2.6 | |||||
Operating expenses | 544.6 | 517.8 | |||||
Operating income | 32.1 | 219.1 | |||||
Other expense, net | (47.9 | ) | (57.3 | ) | |||
(Loss) income before income taxes |